Losing EU funding and collaborations would be disastrous for scientists and patients, says Ian Walker
Payam Gammage is a world-leading expert in how DNA in mitochondria, the cell’s energy factories, mutates to become an engine of cancer. Based at Cancer Research UK’s Beatson Institute near Glasgow, he recently won a €2 million (£1.7m) grant from the European Research Council. But now he faces a difficult choice.
Gammage can either wait in limbo, hoping that the UK’s association to Horizon Europe will be ratified, unable to access the ERC money in the meantime. Or he can gamble on applying to UK Research and Innovation for funding, most likely on different terms to the prestigious grant he’s already won.